15–34 | 35–59 | ≥60 | Total | p-value | |
---|---|---|---|---|---|
Non-multidrug-resistance TB | 692 (100.0%) | 1512 (100.0%) | 2034 (100.0%) | 4238 (100.0%) | |
Resistance to any SLIDa | 2 (0.3%) | 2 (0.1%) | 12 (0.6%) | 16 (0.4%) | 0.082 |
Km resistance | 0 (0.0%) | 1 (0.1%) | 6 (0.3%) | 7 (0.2%) | 0.127 |
Am resistance | 0 (0.0%) | 1 (0.1%) | 5 (0.2%) | 6 (0.1%) | 0.207 |
Cm resistance | 2 (0.3%) | 2 (0.1%) | 10 (0.5%) | 14 (0.3%) | 0.179 |
Sm resistance | 16 (2.3%) | 37 (2.4%) | 56 (2.8%) | 109 (2.6%) | 0.761 |
Multidrug-resistance TB | 42 (100.0%) | 81 (100.0%) | 56 (100.0%) | 179 (100.0%) | |
Resistance to any SLIDa | 5 (11.9%) | 14 (17.3%) | 7 (12.5%) | 26 (14.5%) | 0.633 |
Km resistance | 4 (9.5%) | 13 (16.0%) | 7 (12.5%) | 24 (13.4%) | 0.585 |
Am resistance | 4 (9.5%) | 10 (12.3%) | 7 (12.5%) | 21 (11.7%) | 0.878 |
Cm resistance | 3 (7.1%) | 10 (12.3%) | 7 (12.5%) | 20 (11.2%) | 0.638 |
Sm resistance | 15 (35.7%) | 24 (29.6%) | 20 (35.7%) | 59 (33.0%) | 0.690 |